Stocks and Investing Stocks and Investing
Fri, February 25, 2022
[ 12:00 AM ] - United States, WOPRAI
Scott Devitt Maintained (BABA) at Strong Buy with Decreased Target to $135 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Eddie Leung Maintained (BABA) at Strong Buy with Decreased Target to $193 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jerry Liu Maintained (BABA) at Strong Buy with Decreased Target to $150 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gary Yu Maintained (BABA) at Buy with Decreased Target to $145 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Scott Berg Maintained (AXON) at Strong Buy with Decreased Target to $170 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Paul Chung Upgraded (AXON) to Buy and Decreased Target to $192 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Lewis Maintained (AXNX) at Buy with Decreased Target to $69 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Danielle Antalffy Maintained (AXNX) at Buy with Increased Target to $65 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Baumgartner Maintained (BYND) at Hold with Decreased Target to $45 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Lavery Maintained (BYND) at Hold with Decreased Target to $50 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ken Goldman Maintained (BYND) at Sell with Decreased Target to $32 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bobby Burleson Maintained (BYND) at Hold with Decreased Target to $50 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Chris Pierce Maintained (CARG) at Strong Buy with Increased Target to $52 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Adam Tindle Maintained (ALRM) at Strong Buy with Decreased Target to $85 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Curt Woodworth Maintained (AMBP) at Buy with Decreased Target to $12 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matt Borsch Upgraded (AMED) to Buy and Held Target at $190 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Wiederhorn Maintained (AMED) at Buy with Decreased Target to $200 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
A.J. Rice Maintained (AMED) at Buy with Decreased Target to $195 on, Feb 25th, 2022
Thu, February 24, 2022
[ 12:00 AM ] - United States, WOPRAI
Bill Sutherland Maintained (AMED) at Strong Buy with Decreased Target to $175 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mayank Tandon Maintained (ALKT) at Strong Buy with Decreased Target to $22 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Andrew Berens Maintained (AZN) at Buy with Increased Target to $70 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Alex Yao Maintained (BABA) at Buy and Held Target at $180 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Fish Maintained (BAND) at Buy with Decreased Target to $51 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $41 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jonathan Reeder Maintained (AWR) at Hold with Decreased Target to $86 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Boss Maintained (BIRD) at Hold with Decreased Target to $240 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Erinn Murphy Maintained (BIRD) at Buy with Decreased Target to $320 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Nowak Maintained (BKNG) at Hold on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Stephen Ju Maintained (BKNG) at Buy on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $125 on, Feb 24th, 2022

Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $125 on, Feb 24th, 2022


Published on 2024-10-27 19:49:45 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $121 to $125 on, Feb 24th, 2022.

Christopher has made no other calls on BMRN in the last 4 months.



There are 4 other peers that have a rating on BMRN. Out of the 4 peers that are also analyzing BMRN, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $90 on, Monday, November 22nd, 2021


These are the ratings of the 3 analyists that currently disagree with Christopher

  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $115 on, Monday, November 22nd, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $105 on, Monday, November 22nd, 2021
  • Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, November 22nd, 2021

Contributing Sources